Bridget A Ross sold $560k of LMAT
director at LEMAITRE VASCULAR INC. 5,044 shares at an average of $111.10, traded May 7, 2026, filed May 11, 2026.
Score components
- +15RoleDirector
- +19Trade size$560k at market
- +20Share of holdings soldSold 56% of holdings
- +15Cluster4 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-26-217103, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 7, 2026 | MOption exercise Common Stock | +3,444 | $48.60 | $167k | 7,386 | May 11, 2026 |
| May 7, 2026 | MOption exercise Common Stock | +1,600 | $47.19 | $76k | 8,986 | May 11, 2026 |
| May 7, 2026 | SOpen-market sale Common Stock | -5,044 | $111.10 | $560k | 3,942 | May 11, 2026 |
| May 7, 2026 | MOption exercise Stock Option (Right to Buy)derivative | -3,444 | $0.00 | $0 | 0 | May 11, 2026 |
| May 7, 2026 | MOption exercise Stock Option (Right to Buy)derivative | -1,600 | $0.00 | $0 | 1,609 | May 11, 2026 |
Related signals
Other insiders at LEMAITRE VASCULAR INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 42Moderate | LEMAITRE VASCULAR INC | Lawrence J Jasinski director | $434k 3,943 shares | -46% | |
| 54Moderate | LEMAITRE VASCULAR INC | Trent G Kamke Senior V. P., Operations | $313k 2,928 shares | -44% | |
| 65Notable | LEMAITRE VASCULAR INC | George W LeMaitre Chairman and CEO | $5.0M 46,481 shares | -3% | |
| 39Weak | LEMAITRE VASCULAR INC | Trent G Kamke Senior V. P., Operations | $285k 2,625 shares | -28% | |
| 55Moderate | LEMAITRE VASCULAR INC | David B Roberts President and Director | $357k 3,312 shares | -18% | |
| 30Weak | LEMAITRE VASCULAR INC | Trent G Kamke Senior V. P., Operations | $115k 1,044 shares | -14% | |
| 35Weak | LEMAITRE VASCULAR INC | George W LeMaitre Chairman and CEO | $22M 205,930 shares | -12% | |
| 54Moderate | LEMAITRE VASCULAR INC | David B Roberts President and Director | $904k 8,464 shares | -32% | |
| 44Moderate | LEMAITRE VASCULAR INC | Lawrence J Jasinski director | $91k 976 shares | -17% | |
| 56Moderate | LEMAITRE VASCULAR INC | John A Roush director | $695k 7,500 shares | -195% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.